Drug name - Juluca
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8080551 | VIIV HLTHCARE | HIV inhibiting pyrimidines derivatives |
Apr, 2023
(6 months from now) | |
| US7125879 | VIIV HLTHCARE | HIV inhibiting pyrimidines derivatives |
Apr, 2025
(2 years from now) | |
| US8129385 | VIIV HLTHCARE | Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness |
Oct, 2027
(5 years from now) | |
| US9242986 | VIIV HLTHCARE | Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates |
Dec, 2029
(7 years from now) | |
| US10426780 | VIIV HLTHCARE | Antiviral therapy |
Jan, 2031
(8 years from now) | |
| CN101346376A | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Inhibitory Activity On Hiv Integrase |
Jul, 2011
(11 years ago) | |
| CN101056673A | VIIV HLTHCARE | 4-[[4-[[4-(2-Cyanovinyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidyl]Amino] Benzonitrile Hydrochloride |
Jun, 2015
(7 years ago) | |
| CN101816658A | VIIV HLTHCARE | Pyramine Derivatives For Inhibiting Hiv |
Aug, 2022
(a month ago) | |
| CN101816658B | VIIV HLTHCARE | Hiv Inhibiting Pyrimidines Derivatives |
Aug, 2022
(a month ago) | |
| CN1541215A | VIIV HLTHCARE | Hiv Inhibiting Pyrimidine Derivatives |
Aug, 2022
(a month ago) | |
| CN100509801C | VIIV HLTHCARE | Hiv Inhibiting Pyrimidines Derivatives |
Aug, 2022
(a month ago) | |
| CN101060844B | VIIV HLTHCARE | Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors |
Sep, 2024
(1 year, 11 months from now) | |
| CN101068597B | VIIV HLTHCARE | 4 - ((4 - ((4 - (2) -2, 6 -) Dimethylphenyl Amido) -2 - Pyrimidyl) Amido) Benzonitrile |
Sep, 2024
(1 year, 11 months from now) | |
| CN101068597A | VIIV HLTHCARE | Fumaric Acid Salt Of 4-((4-((4-(2-Cyanovinyl)-2, 6-) Dimethylphenyl Amido)-2- Pyrimidyl) Amido) Benzonitrile |
Sep, 2024
(1 year, 11 months from now) | |
| CN101060844A | VIIV HLTHCARE | Composition Of Rt Inhibitor And Nnrti Containing Pyrimidine |
Sep, 2024
(1 year, 11 months from now) | |
| CN101212903A | VIIV HLTHCARE | Polycyclic Carbamoyl Pyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| CN101212903B | VIIV HLTHCARE | Polycyclic Carbamoyl Pyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| CN102245182A | VIIV HLTHCARE | Synthesis Of Carbamoyl Pyridone Hiv Integrase Inhibitors And Intermediate |
Dec, 2029
(7 years from now) | |
| CN102245182B | VIIV HLTHCARE | Carbamoyl Pyridone Hiv Integrase Inhibitors And Intermediates For Synthesis |
Dec, 2029
(7 years from now) | |
| CN102791129B | VIIV HLTHCARE | Antiviral Therapy |
Jan, 2031
(8 years from now) | |
| CN102791129A | VIIV HLTHCARE | Antiviral Therapy |
Jan, 2031
(8 years from now) | |
| CN105311033B | VIIV HLTHCARE | Antiviral Therapy |
Jan, 2031
(8 years from now) | |
| CN105311033A | VIIV HLTHCARE | Antiviral Therapy |
Jan, 2031
(8 years from now) | |
| IN222987B | VIIV HLTHCARE | A Pyrimidine Compound Of Formula (I) |
Aug, 2022
(a month ago) | |
| IN200400265P1 | VIIV HLTHCARE | Hiv Inhibiting Pyrimidines Derivatives |
Aug, 2022
(a month ago) | |
| IN373756B | VIIV HLTHCARE | Process For The Preparation Of Carbamoylpyrid One Hiv Integrase Inhibitors |
Dec, 2029
(7 years from now) | |
| IN201838011858A | VIIV HLTHCARE | Process For The Preparation Of Carbamoylpyridone Hiv Integrase Inhibitors |
Dec, 2029
(7 years from now) | |
| IN201201811P2 | VIIV HLTHCARE | Antiviral Therapy |
Jan, 2031
(8 years from now) | |
| IN301970B | VIIV HLTHCARE | Antiviral Therapy |
Jan, 2031
(8 years from now) | |
| EP1663240A1 | VIIV HLTHCARE | Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors |
Jul, 2020
(2 years ago) | |
| EP1663240B1 | VIIV HLTHCARE | Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors |
Jul, 2020
(2 years ago) | |
| EP1632232A1 | VIIV HLTHCARE | Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile |
Feb, 2022
(7 months ago) | |
| EP1632232B1 | VIIV HLTHCARE | Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile |
Feb, 2022
(7 months ago) | |
| EP2298761B1 | VIIV HLTHCARE | Hiv Inhibiting Pyrimidines Derivatives |
Aug, 2022
(a month ago) | |
| EP2298761A1 | VIIV HLTHCARE | Hiv Inhibiting Pyrimidines Derivatives |
Aug, 2022
(a month ago) | |
| EP3808743B1 | VIIV HLTHCARE | Hiv Replication Inhibiting Pyrimidines |
Aug, 2022
(a month ago) | |
| EP3808743A1 | VIIV HLTHCARE | Hiv Replication Inhibiting Pyrimidines |
Aug, 2022
(a month ago) | |
| EP1789139A1 | VIIV HLTHCARE | Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile |
Sep, 2025
(2 years from now) | |
| EP1789139B1 | VIIV HLTHCARE | Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile |
Sep, 2025
(2 years from now) | |
| EP1852434A1 | VIIV HLTHCARE | Bicyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibiting Activity |
Feb, 2026
(3 years from now) | |
| EP1852434B1 | VIIV HLTHCARE | Bicyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibiting Activity |
Feb, 2026
(3 years from now) | |
| EP1852434A4 | VIIV HLTHCARE | Bicyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibiting Activity |
Feb, 2026
(3 years from now) | |
| EP2527007B1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP3372281A1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP3187225B1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP3045206A1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP3284520A1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP3284520B1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP3187225A1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP3372281B1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP3045206B1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP2527007A1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP1874117B8 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP1874117A4 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP2465580A1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivatives Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP1874117A1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP1874117B1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP2465580B1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivatives Having Hiv Integrase Inhibitory Activity |
Apr, 2026
(3 years from now) | |
| EP1950212B1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Inhibitory Activity On Hiv Integrase |
Oct, 2026
(4 years from now) | |
| EP1950212A4 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Inhibitory Activity On Hiv Integrase |
Oct, 2026
(4 years from now) | |
| EP1950212A1 | VIIV HLTHCARE | Polycyclic Carbamoylpyridone Derivative Having Inhibitory Activity On Hiv Integrase |
Oct, 2026
(4 years from now) | |
| EP1419152A1 | VIIV HLTHCARE | Hiv Inhibiting Pyrimidines Derivatives |
Nov, 2026
(4 years from now) | |
| EP1419152B1 | VIIV HLTHCARE | Hiv Inhibiting Pyrimidines Derivatives |
Nov, 2026
(4 years from now) | |
| EP2376080A1 | VIIV HLTHCARE | Synthesis Of Carbamoylpyridone Hiv Integrase Inhibitors And Intermediates |
Dec, 2029
(7 years from now) | |
| EP2376080B1 | VIIV HLTHCARE | Synthesis Of Carbamoylpyridone Hiv Integrase Inhibitors And Intermediates |
Dec, 2029
(7 years from now) | |
| EP2376080A4 | VIIV HLTHCARE | Synthesis Of Carbamoylpyridone Hiv Integrase Inhibitors And Intermediates |
Dec, 2029
(7 years from now) | |
| EP3127542A1 | VIIV HLTHCARE | Antiviral Therapy |
Jan, 2031
(8 years from now) | |
| EP2531027A1 | VIIV HLTHCARE | Therapeutic Combination Comprising Dolutegravir, Abacavir And Lamivudine |
Jan, 2031
(8 years from now) | |
| EP3127542B1 | VIIV HLTHCARE | Antiviral Therapy |
Jan, 2031
(8 years from now) | |
| EP2531027A4 | VIIV HLTHCARE | Antiviral Therapy |
Jan, 2031
(8 years from now) | |
| EP2531027B1 | VIIV HLTHCARE | Therapeutic Combination Comprising Dolutegravir, Abacavir And Lamivudine |
Jan, 2031
(8 years from now) | |
| EP2932970A1 | VIIV HLTHCARE | Antiviral Therapy |
Jan, 2031
(8 years from now) | |
| EP2932970B1 | VIIV HLTHCARE | Antiviral Therapy |
Jan, 2031
(8 years from now) | |
Drugs and Companies using DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE ingredient
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 50MG BASE;EQ 25MG BASE | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.